# DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR

> **NCT02073851** · NA · COMPLETED · sponsor: **Keystone Heart** · enrollment: 12 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** TriGuard™HDH

## Key facts

- **NCT ID:** NCT02073851
- **Lead sponsor:** Keystone Heart
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-08
- **Final completion:** 2014-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2015-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02073851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02073851, "DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT02073851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*